Bethany Sensenig's Insider Trades & SAST Disclosures

Bethany Sensenig's most recent trade in Supernus Pharmaceuticals Inc was a trade of 5,369 Common Stock done at an average price of $42.2 . Disclosure was reported to the exchange on Aug. 14, 2025.

Share

Note

This is a custom search result for pattern Bethany Sensenig.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.

All Superstars

"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches "Balanced Fund" but not "Balanced Growth Fund" Balanced Fund: Use this format without quotation marks to search for all funds related to the term "Balanced Fund" The results may include "Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".

Stock	Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Supernus Pharmaceuticals Inc	Bethany Sensenig	Director	Sale of securities on an exchange or to another person at price $ 42.25 per share.	14 Aug 2025	5,369	0 (0%)	0%	42.2	226,840	Common Stock
Supernus Pharmaceuticals Inc	Bethany Sensenig	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	22 Feb 2025	5,369	5,369 (0%)	0%		0	Common Stock
Supernus Pharmaceuticals Inc	Bethany Sensenig	Director	Sale or transfer of securities back to the company at price $ 0.00 per share.	22 Feb 2025	5,369	0	-		-	Restricted Stock Units
Supernus Pharmaceuticals Inc	Bethany Sensenig	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	19 Feb 2025	7,296	7,296	-		-	Director Stock Option (Right to Buy)
Supernus Pharmaceuticals Inc	Bethany Sensenig	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	19 Feb 2025	4,475	4,475	-		-	Restricted Stock Unit
Supernus Pharmaceuticals Inc	Bethany Sensenig	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	22 Feb 2024	8,252	8,252	-		-	Director Stock Option (Right to Buy)
Supernus Pharmaceuticals Inc	Sensenig Bethany	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	22 Feb 2024	5,369	5,369	-		-	Restricted Stock Units
Supernus Pharmaceuticals Inc	Bethany Sensenig	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Aug 2023	24,153	24,153	-		-	Director Stock Option (Right to Buy)

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades